Ikarian Capital, LLC 13D and 13G filings for Cyclacel Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:34 pm Sale |
2021-12-31 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital, LLC | 414 1.000% |
-1,252 (-75.14%) |
Filing |
| 2021-01-08 9:59 pm Purchase |
2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital, LLC | 1,667 8.200% |
1,667 (New Position) |
Filing |